Skip to main content

Table 2 Clinical factors related to successful Helicobacter pylori eradication

From: Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication

 

TT

SET

OR

95% CI

P value

OR

95% CI

P value

Univariate analyses

 Male gender

0.941

0.637 – 1.391

0.761

1.039

0.436 – 2.477

0.932

 Age < 50 years

0.724

0.481 – 1.089

0.121

1.634

0.702 – 3.807

0.255

 Residence – Seoul

0.819

0.509 – 1.320

0.413

1.154

0.375 – 3.553

0.803

 Alcohol

0.942

0.628 – 1.415

0..775

0.909

0.391 – 2.115

0.824

 Smoking

0.883

0.553 – 1.411

0.602

0.802

0.329 – 1.955

0.628

 Diabetes mellitus

1.375

0.770 – 2.455

0.281

1.190

0.330 – 4.289

0.790

 Hypertension

0.933

0.579 – 1.502

0.775

1.131

0.426 – 2.999

0.805

Indication

 Peptic ulcer disease

0.690

0.456 – 1.043

0.079

1.559

0.567 – 4.284

0.389

 Malignant disease

0.647

0.297 – 1.410

0.273

1.604

0.461 – 5.581

0.458

Multivariate analysis

 Male gender

0.941

0.635 – 1.394

0.761

1.013

0.419 – 2.449

0.976

 Age < 50 years

0.718

0.476 – 1.083

0.114

1.708

0.717 – 4.068

0.227

 Residence – Seoul

0.792

0.490 – 1.282

0.343

1.203

0.280 – 3.831

0.750

Indication

 Peptic ulcer disease

0.679

0.447 – 1.030

0.069

1.538

0.554 – 4.272

0.409

 Malignant disease

0.607

0.277 – 1.330

0.212

1.877

0.517 – 6.817

0.338

  1. TT triple therapy, SET sequential therapy, OR odds ratio, CI confidence interval